Skip to content
lifestyle.gopreneurs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Solid Biosciences Inc.
Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
October 20, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Solid Biosciences to Participate at Upcoming Investor Conferences
September 2, 2026
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
Solid Biosciences to Participate at Upcoming Investor Conferences
June 1, 2026
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
May 24, 2026
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May 23, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2026
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
May 22, 2026
1
2
Next Page
→